会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 13. 发明授权
    • Identification of genes or polypeptides the expression of which correlates to fertility, ovarian function and/or fetal/newborn viability
    • 识别基因或多肽,其表达与生育力,卵巢功能和/或胎儿/新生儿存活力相关
    • US07858308B2
    • 2010-12-28
    • US11584580
    • 2006-10-23
    • Jose CibelliJavier CrosbyEmilio FernandezArif KocabasGuilherme Jordao De Magalhaes Rosa
    • Jose CibelliJavier CrosbyEmilio FernandezArif KocabasGuilherme Jordao De Magalhaes Rosa
    • C12Q1/68C12P19/34A01N43/04
    • C12Q1/6883C12Q2600/158
    • A genetic means of determining whether a female subject produces “pregnancy competent” oocytes is provided. The means comprises detecting the level of expression of one or more genes that are expressed at characteristic levels (upregulated or downregulated) in cumulus cells derived from pregnancy competent oocytes. This characteristic gene expression level, or pattern referred to herein as the “pregnancy signature”, also can be used to identify subjects with underlying conditions that impair or prevent the development of a viable pregnancy, e.g., pre-menopausal condition, other hormonal dysfunction, ovarian dysfunction, ovarian cyst, cancer or other cell proliferation disorder, autoimmune disease and the like. Microarrays containing “pregnancy signature” genes or corresponding polypeptides provide another preferred aspect of the invention. Still further, the subject invention can be used to derive animal models, e.g., non-human primate animal models, for the evaluation of the efficacy of putative female fertility treatments.
    • 提供确定女性受试者是否产生“怀孕受精”卵母细胞的遗传手段。 该方法包括检测在源于妊娠合格卵母细胞的卵丘细胞中以特征水平(上调或下调)表达的一种或多种基因的表达水平。 这种特征性基因表达水平或本文称为“怀孕签名”的模式也可以用于鉴定有潜在病症的受试者,其损害或预防可行妊娠的发展,例如绝经前期,其他激素功能障碍, 卵巢功能障碍,卵巢囊肿,癌症或其他细胞增殖障碍,自身免疫性疾病等。 包含“怀孕特征”基因或相应多肽的微阵列提供本发明的另一优选方面。 此外,本发明可以用于衍生动物模型,例如非人灵长类动物模型,以评估推定的女性生育力治疗的功效。
    • 14. 发明申请
    • Identification of genes or polypeptides the expression of which correlates to fertility, ovarian function and/or fetal/newborn viability
    • 识别基因或多肽,其表达与生育力,卵巢功能和/或胎儿/新生儿存活力相关
    • US20070238111A1
    • 2007-10-11
    • US11584580
    • 2006-10-23
    • Jose CibelliJavier CrosbyEmilio FernandezArif KocabasGuilherme Jordao Rosa
    • Jose CibelliJavier CrosbyEmilio FernandezArif KocabasGuilherme Jordao Rosa
    • C12Q1/68
    • C12Q1/6883C12Q2600/158
    • A genetic means of determining whether a female subject produces “pregnancy competent” oocytes is provided. The means comprises detecting the level of expression of one or more genes that are expressed at characteristic levels (upregulated or downregulated) in cumulus cells derived from pregnancy competent oocytes. This characteristic gene expression level, or pattern referred to herein as the “pregnancy signature”, also can be used to identify subjects with underlying conditions that impair or prevent the development of a viable pregnancy, e.g., pre-menopausal condition, other hormonal dysfunction, ovarian dysfunction, ovarian cyst, cancer or other cell proliferation disorder, autoimmune disease and the like. Microarrays containing “pregnancy signature” genes or corresponding polypeptides provide another preferred aspect of the invention. Still further, the subject invention can be used to derive animal models, e.g., non-human primate animal models, for the evaluation of the efficacy of putative female fertility treatments.
    • 提供确定女性受试者是否产生“怀孕受精”卵母细胞的遗传手段。 该方法包括检测在源于妊娠合格卵母细胞的卵丘细胞中以特征水平(上调或下调)表达的一种或多种基因的表达水平。 这种特征性基因表达水平或本文称为“怀孕签名”的模式也可以用于鉴定有潜在病症的受试者,其损害或预防可行妊娠的发展,例如绝经前期,其他激素功能障碍, 卵巢功能障碍,卵巢囊肿,癌症或其他细胞增殖障碍,自身免疫性疾病等。 包含“怀孕特征”基因或相应多肽的微阵列提供本发明的另一优选方面。 此外,本发明可以用于衍生动物模型,例如非人灵长类动物模型,以评估推定的女性生育力治疗的功效。
    • 16. 发明申请
    • Production of chimeric bovine or porcine animals using cultured inner cell mass
    • 使用培养的内细胞块生产嵌合牛或猪动物
    • US20060021070A1
    • 2006-01-26
    • US11024010
    • 2004-12-28
    • Steven SticeJose CibelliJames RoblPaul GoluekeF. LeonD. Jerry
    • Steven SticeJose CibelliJames RoblPaul GoluekeF. LeonD. Jerry
    • A01K67/027
    • C12N15/8771A01K2217/05C12N15/8778
    • Novel cultured inner cell mass (CICM) cells, and cell lines, derived from ungulates, in particular, pigs and cows, and methods for their preparation are provided. The subject CICMs possess similar morphology and express cell markers identically or substantially similarly to ICMs of undifferentiated developing embryos for prolonged culturing periods. Heterologous DNA is inserted into the subject CICM cells and cell lines so as produce transgenic CICM cell which are introduced into non-human fertilized embryos to produce transgenic chimeric embryos. The transgenic chimeric embryos are transferred into recipient females where they are permitted to develop into transgenic chimeric fetuses. Recipient females give birth to transgenic chimeric animals which are capable of transmitting the heterologous DNA to their progeny. Transgenic CICM cells are also used to produce cloned transgenic embryos, fetuses and offspring.
    • 提供了新颖的培养的内细胞团(CICM)细胞和源自有蹄类动物,特别是猪和牛的细胞系及其制备方法。 受试者CICM具有与未分化发育的胚胎的ICM相似或基本上类似于延长培养期的相似形态和表达细胞标记。 将异源DNA插入受试者CICM细胞和细胞系中,以产生转入非人受精胚胎以产生转基因嵌合胚胎的转基因CICM细胞。 将转基因嵌合胚胎转移到受体雌性中,在其中允许其转化为转基因嵌合胎儿。 受体女性产生能够将异源DNA转移到其后代的转基因嵌合动物。 转基因CICM细胞也用于产生克隆的转基因胚胎,胎儿和后代。
    • 18. 发明申请
    • Methods of repairing tandemly repeated DNA sequences and extending cell life-span nuclear transfer
    • 修复串联重复DNA序列和延长细胞寿命核转移的方法
    • US20050255596A1
    • 2005-11-17
    • US11079930
    • 2005-03-09
    • Michael WestRobert LanzaJose Cibelli
    • Michael WestRobert LanzaJose Cibelli
    • C12N5/08C12N15/63C12N15/85C12Q1/68
    • C12N15/85C12N2517/04
    • This invention relates to methods for rejuvenating normal somatic cells and for making normal somatic cells of a different type having the same genotype as a normal somatic cell of interest. These cells have particular application in cell and tissue transplantation. Also encompassed are methods of re-cloning cloned animals, particularly methods where the offspring of cloned mammals are designed to be genetically altered in comparison to their cloned parent, e.g., that are “hyper-young.” These animals should be healthier and possess desirable properties relative to their cloned parent. Also included are methods for activating endogenous telomerase, EPC-1 activity, and or the ALT pathway and/or extending the life-span of a normal somatic cell, and other genes associated with cell aging and proliferation capacity.
    • 本发明涉及用于恢复正常体细胞和用于制备具有与感兴趣的正常体细胞相同基因型的不同类型的正常体细胞的方法。 这些细胞在细胞和组织移植中具有特殊应用。 还包括重新克隆克隆动物的方法,特别是其克隆的哺乳动物的后代被设计为与其克隆的亲本(例如“超年龄”)相比被遗传改变的方法。 这些动物应该更健康,并且相对于其克隆的亲本具有所需的性质。 还包括用于激活内源性端粒酶,EPC-1活性和/或ALT途径和/或延长正常体细胞的寿命和与细胞衰老和增殖能力相关的其它基因的方法。